All stock reports

HCG evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-10T14:01:34.479195+00:00

Metrics

latest_annual_period
2026-03-31
revenue
25384300000.0
net_income
137600000.0
operating_cash_flow
3471000000.0
free_cash_flow
550000000.0
total_assets
39225400000.0
total_liabilities
25123300000.0
total_equity
13319700000.0
cash
5360500000.0
total_debt
17353600000.0
revenue_growth
0.14197089322266465
earnings_growth
-0.6901598739022743
net_margin
0.005420673408366589
roe
0.010330563000668183
debt_to_equity
1.3028521663400827
cash_conversion
25.225290697674417
free_cash_flow_margin
0.021666935861930407
trailing_pe
125.5
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-789974d7d6ca7f7d7b606985562a82236ecded8e9f00c99b3b51bac97c939a5d
Policy
stock-decisions-v1
Evidence bundle hash
8a598f1e56e7e2e710e4de51360cd68827d3080ab499988cb896f7809bc510cb
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 100698712cf95271f0e1b3ccd649bdbbd83fa8538806f4a6ce3848c0186d973a
  • daily-price: 720ae6240d93cc7e8f2700f6d17b205a37ffbfc303e05b6d65b0a72c5153fbcf
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 5-session price return was -4.61%. The trailing 20-session price return was -4.37%. The trailing 60-session price return was 5.40%. The trailing 250-session price return was 3.30%. Average cached traded value over twenty sessions was INR 95,488,267.

Risks

The closing price was -13.85% below its highest close in the available trailing year. The cached financial metric net margin is 0.005420673408366589. The cached financial metric roe is 0.010330563000668183. The cached financial metric debt to equity is 1.3028521663400827. Financial data check: balance_sheet_equation: difference=782400000.00. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.14197089322266465. The cached financial metric cash conversion is 25.225290697674417. The cached financial metric free cash flow margin is 0.021666935861930407.

Cached observations and evidence limits